Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had revenue of $26.08M in the quarter ending September 30, 2024, with 147.62% growth. This brings the company's revenue in the last twelve months to $65.18M, up 37.64% year-over-year. In the year 2023, Recursion Pharmaceuticals had annual revenue of $44.58M with 11.88% growth.

• Revenue (ttm): $65.18M
• Revenue Growth: +37.64%
• P/S Ratio: 25.92
• Revenue / Employee: $130,368
• Employees: 500
• Market Cap: 2.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	44.58M	4.73M	11.88%
Dec 31, 2022	39.84M	29.67M	291.46%
Dec 31, 2021	10.18M	6.22M	156.89%
Dec 31, 2020	3.96M	1.64M	70.85%
Dec 31, 2019	2.32M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.